LALS in-silico team excels in drug discovery design efforts in collaboration with medicinal chemistry, structural biology, biology and DMPK teams, by conducting molecular modelling studies
VISION & MISSION
LALS’s vision is to become the ideal drug discovery, development and manufacturing partner to the pharmaceutical industry and in doing so to enable the creation of innovative healthcare products.
Will improve the lives of people while building a pre-eminent company with a culture of initiative, excellence and co-operation focused on exceeding expectations of the community, employees, partners and investors.
To deliver cutting edge technological and scientific solutions in the field of biopharmaceutics. We offer our clients a wide range of integrated drug discovery and development solutions.
We offer our clients a wide range of integrated drug discovery and development solutions, with core expertise founded in synthetic, medicinal and process chemistry, further augmented by preclinical services including DMPK and toxicology.
SCIENTIFIC ADVISORY TEAM
“Excellent manufacturing and quality systems. Very knowledgeable and experienced management team.”
– Japanese Big Pharma, Medicinal Chemistry
“We were very impressed with the work of the Laxai team. The successful completion of the project is important, but to us, the desire to understand the underlying science is also critical. Successful completion of projects such as this allows our scientists to have a greater confidence in Laxai and also ensures better rapport stemming from the shared vision of scientific understanding.”
– US MNC from West Coast, Advanced Intermediates
“Thanks to the entire team at Laxai for being such gracious hosts and taking the time to show us around the facility. The facility and capabilities were most impressive and the knowledge and understanding of the entire process by the staff was commendable. Looking forward to a continued collaboration with Laxai.”
– US based Big Pharma, Process Chemistry
“We are very pleased with the quality of development and product your company provided to us to accelerate our development program. Your team have displayed exceptional scientific skills and worked with great sincerity and generousness. We sincerely appreciate your responsiveness and efforts put into supply of product. Your efforts have helped our company to achieve desired milestones interns fulfillment of our mission.”
– Japanese Multinational Company
To develop First in class (FIC) antibiotics against life threatening infections
LALS has been a strategic partner to ABAC Therapeutics
Technical platform validation
Delivered Pre-clinical Candidate with clean IP acting against gram-negative bacteria with unique mode of action
Aptose Biosciences Announces Exclusive collaborations with LALS for New Multi-Targeting Epigenetic Therapeutic Agents (10 November 2015)
LALS to Design Next Generation Epigenetic Therapeutics
LALS has been contributed in reviewing the target selection and devised the unique strategy with clear differentiation